Tuberculosis screening in migrants to the EU/EEA and UK
- PMID: 37918879
- PMCID: PMC11851637
- DOI: 10.1183/13993003.01230-2023
Tuberculosis screening in migrants to the EU/EEA and UK
Conflict of interest statement
Conflict of interest: C. Lange is supported by the German Center of Infection Research (DZIF); in addition, C. Lange has provided consultation to Insmed, a company that produced liposomal amikacin as an inhalative suspension for the treatment of NTM-PD, received speaker honoraria from Insmed, Gilead, Janssen and GSK, and is a member of the data safety board for trials of Medicines sans Frontiers, outside the submitted work. The other authors have no potential conflicts of interest to disclose.
Comment in
-
Reply: Tuberculosis screening in migrants to the EU/EEA and UK.Eur Respir J. 2023 Nov 2;62(5):2301535. doi: 10.1183/13993003.01535-2023. Print 2023 Nov. Eur Respir J. 2023. PMID: 37918880 Free PMC article.
Comment on
-
Drivers determining tuberculosis disease screening yield in four European screening programmes: a comparative analysis.Eur Respir J. 2023 Oct 12;62(4):2202396. doi: 10.1183/13993003.02396-2022. Print 2023 Oct. Eur Respir J. 2023. PMID: 37230498 Free PMC article.
References
-
- Vasiliu A, Koehler N, Altpeter E, et al. Tuberculosis in foreign-born persons in Europe. Euro Surveill 2023; 28: 10.2807/1560-7917.ES.2023.28.42.2300051. - DOI
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical